Halozyme Therapeutics Inc(HALO)— 技術面狀態
數據截至2026-09-21 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades +15.3% vs the 50-day and +46.4% vs the 200-day average, 1.8% below the 52-week high and +82% off the 52-week low; a golden cross printed 55 sessions ago. Computed from daily closes.
Ranked #32 on today’s Directional Flow — Rising fastest list (scan of 2026-09-21).
移動平均線狀態
- 相對20日均線+2.8%
- 相對50日均線+15.3%
- 相對200日均線+46.4%
- 52週區間低於52週高點1.8% · 高於52週低點82%
- 連續走勢連續1個交易日下跌
- 均線交叉黃金交叉(55個交易日前)
- 50日均線交叉股價向上穿越50日均線(91個交易日前)
- 隨機指標%K 74.7 · %D 81.1(死亡交叉)
FAQ · from the current data · as of 2026-09-21
Quick answers
HALO目前的Closelook訊號是什麼?
Uptrend stack intact — Trades +15.3% vs the 50-day and +46.4% vs the 200-day average, 1.8% below the 52-week high and +82% off the 52-week low; a golden cross printed 55 sessions ago. Computed from daily closes.(截至2026-09-21;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
HALO目前是否位於50日與200日均線上方?
截至2026-09-21,Halozyme Therapeutics Inc位於50日均線上方(+15.3%),200日均線上方(+46.4%);距20日均線+2.8%。
HALO距52週高點有多遠?
截至2026-09-21,低於52週高點1.8%,高於52週低點82%。
Related in the Closelook universe
then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- UCB.BR UCB SAindustry
- MRNA Moderna Incindustry
- TWST Twist Bioscience Corpindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- RXRX Recursion Pharmaceuticals Incindustry
- SMMT Summit Therapeutics PLCindustry
- GMAB Genmab ASindustry
- CRSP Crispr Therapeutics AGindustry
- IBRX Immunitybio Incindustry
- SRPT Sarepta Therapeutics Incindustry
- TGTX TG Therapeutics Incindustry
- EXEL Exelixis Incindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- INCY Incyte Corporationindustry
- PCVX Vaxcyte Incindustry